20 likes | 38 Views
223 Pages Report] Increasing global incidence & prevalence of cancer to drive the market demand for radiotherapy devices; reaching a market value of USD 9.47 Billion by 2022
E N D
What are the Global Growth Factors? Technological advancements in the field of radiotherapy and rising incidence of cancer are the major factors driving the growth of the global radiotherapy market. Additionally, rapid growth in the aging population, growing adoption of radiotherapy for the treatment of cancer, and increasing number of conferences and symposia focusing on the advancements in radiotherapy are some of the other factors driving the growth of this market. In addition, emerging markets (such as China and India) are poised to offer new growth opportunities for key Radiotherapy Market players during the next decade. What The Experts Says about the Market Growth? The global radiotherapy market is projected to reach $9.47 billion by 2022 at a CAGR of 6.8% Browse and in-depth TOC on "Radiotherapy Market" 117 – Tables 37 - Figures 223 - Pages View more @ https://www.marketsandmarkets.com/Market-Reports/radiotherapy-monitoring-devices- market-567.html On the basis of product type, the electron-emitting high-energy linear accelerators segment is expected to account for the largest share of the external beam radiotherapy market in 2016. The development of advanced linear accelerators and growing adoption of these devices are some of the factors driving the growth of this market. On the basis of application, the prostate cancer segment held the largest share in both the internal and external beam radiotherapy markets in 2016, owing to the non-invasive nature of radiotherapy, rising incidence of prostate cancer in the geriatric male population, and high success rates achieved with radiotherapy. Geographical Analysis: Geographically, the radiotherapy market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2016, followed by Europe. A number of factors such as technological advancements in radiotherapy equipment, growing number of cancer cases, and rising focus of key players on expanding their presence in North America are driving the growth of the radiotherapy market in this region. Key Market Players: Varian Medical Systems, Inc. (U.S.) and Elekta AB (Sweden) dominated the global radiotherapy market. Other prominent players include Accuray Incorporated (U.S.), Ion Beam Applications (IBA) (Belgium), Nordion, Inc. (Canada), C. R. Bard, Inc. (U.S.), Isoray Medical, Inc. (U.S.), RaySearch Laboratories (Sweden), Mevion Medical Systems, Inc. (U.S.), and Mitsubishi Electric Corporation (Japan). Radiotherapy Market by Type (External (IGRT, IMRT, 3D-CRT), Internal (LDR, HDR) & Systemic),
Product (Proton Beam, Cyberknife, LINAC, Seed, Samarium), Application (Prostate, Breast, Cervical), End User, and Region - Global Forecasts to 2022